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Abstract
Background: Kabuki syndrome (KS) is a multiple congenital anomaly syndrome characterized by
specific facial features, mild to moderate mental retardation, postnatal growth delay, skeletal
abnormalities, and unusual dermatoglyphic patterns with prominent fingertip pads. A 3.5 Mb
duplication at 8p23.1-p22 was once reported as a specific alteration in KS but has not been
confirmed in other patients. The molecular basis of KS remains unknown.
Methods: We have studied 16 Spanish patients with a clinical diagnosis of KS or KS-like to search
for genomic imbalances using genome-wide array technologies. All putative rearrangements were
confirmed by FISH, microsatellite markers and/or MLPA assays, which also determined whether
the imbalance was de novo or inherited.
Results: No duplication at 8p23.1-p22 was observed in our patients. We detected complex
rearrangements involving 2q in two patients with Kabuki-like features: 1) a de novo inverted
duplication of 11 Mb with a 4.5 Mb terminal deletion, and 2) a de novo 7.2 Mb-terminal deletion in
a patient with an additional de novo 0.5 Mb interstitial deletion in 16p. Additional copy number
variations (CNV), either inherited or reported in normal controls, were identified and interpreted
as polymorphic variants. No specific CNV was significantly increased in the KS group.
Conclusion: Our results further confirmed that genomic duplications of 8p23 region are not a
common cause of KS and failed to detect other recurrent rearrangement causing this disorder. The
detection of two patients with 2q37 deletions suggests that there is a phenotypic overlap between
the two conditions, and screening this region in the Kabuki-like patients should be considered.
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Background
Kabuki syndrome (KS), also known as Kabuki make-up
syndrome (OMIM 147920), is a multiple congenital
anomaly syndrome independently established by
Niikawa [1] and Kuroki [2] with an estimated incidence of
1 in 32000 newborns [3]. KS is characterized by specific
facial features including long palpebral fissures with ever-
sion of the lateral one-third of the lower eyelid, arched
eyebrows with sparseness of the lateral third, a short colu-
mella with a depressed nasal tip and prominent ears. This
syndrome includes mild to moderate mental retardation,
postnatal growth retardation with final short stature, skel-
etal abnormalities, and unusual dermatoglyphic patterns
with prominent fingertip pads. The majority of reported
patients have been sporadic with similar sex ratio. Several
instances of vertical transmission of KS and KS-like fea-
tures have been reported, making autosomal dominant
inheritance a likely mode of transmission. No consensus
diagnostic criteria have been established yet, but based on
the clinical findings reported by Niikawa et al [1] five car-
dinal manifestations were defined to include patients in
the KS group (peculiar face, skeletal anomalies, derma-
toglyphic abnormalities, mild to moderate mental retar-
dation and postnatal growth deficiency).
Although the cause of KS is currently unknown, numerous
cytogenetic abnormalities have been reported in patients
with a clinical diagnosis of KS [3]. Matsumoto and
Nikawa [4] speculated on a possible microdeletion or
microduplication involving contiguous genes as the cause
of the disorder, given that the KS patients showed a wide
spectrum of multisystemic manifestations and that the
majority of patients were sporadic. Milunsky and Huang
[5] using classic comparative genomic hybridization
(CGH) and fluorescence in situ hybridization (FISH) on
metaphase chromosomes, found a 3.5 Mb duplication at
8p23.1-p22 in 6 unrelated KS patients suggesting that this
alteration may represent a common etiology for the disor-
der. However, this duplication has not been observed in
other multiple patients studied by other groups [6-11]
indicating that it is not a common finding in KS.
Maas et al. have also recently reported a de novo 250 kb
deletion disrupting a single gene of unknown function in
20p12.1,  C20orf133, detected by aCGH in a single KS
patient out of 20 [12].
In order to search for putative microrearrangements
responsible of KS, we have first screened our 16 patients
referred to us with clinical suspicion of KS for 8p22-23
duplications by microsatellite analysis. Subsequently, in
10 patients with adequate DNA, we performed a genome
wide survey of DNA aberrations with two different tech-
nologies: an in-house printed BAC array, with a global
coverage of 23% of the genome and higher density in hot-
spot candidate regions (located between segmental dupli-
cations and subtelomeric positions) and a commercial
oligonucleotide array that spans coding and noncoding
sequences with an average spatial resolution of ~100 kb
(Agilent G4410B).
Methods
Patients and controls
A total of 16 individuals (9 males and 7 females, age range
1–20 years) with clinical manifestations overlapping with
the KS phenotype and referred from several Spanish hos-
pitals were included in the study. All referring physicians
filled out a basic clinical datasheet and sent pictures of
their patients. They all shared at least some of the facial
features of KS that lead to the suspicion of this diagnosis
along with mental retardation (mild to moderate in 12
cases, severe in 2). Other features included short stature
(7/16), skeletal anomalies (13/16), prominent fingertip
pads (14/16), and major visceral anomalies or dysfunc-
tion including congenital heart defect (6/16), urinary
anomalies (3/16), and anogenital anomalies (4/16). We
summarized the major clinical findings in Table 1. Two
patients, KS13 and KS14, had been previously reported
[13].
All patients had normal karyotypes (variable banding res-
olution 400–650) except for KS14 who had a balanced
translocation inherited from his mother,
46,XY,t(15;17)(q15;q21) [13]. Patient KS12 had also
been evaluated for the 22q11.2 deletion by FISH, with
negative result. Blood samples from the patient and par-
ents were obtained under institutional review board-
approved informed consent and genomic DNA was
extracted by the salting out method using the Puregene®
DNA purification Kit (Gentra Systems). Poor DNA quality
or scarce amount, unsuitable for some of the studies, was
obtained from 6 samples.
DNA samples isolated from peripheral blood from 120
healthy unrelated controls (anonymous blood donors)
were used to prepare reference pools (50 males and 50
females) for hybridization experiments. DNAs from 20
control individuals (10 males and 10 females) as well as
patients with other disorders (n = 130) were used in order
to define pathological changes in DNA dosage, and to
estimate and compare frequencies of CNV for association
studies.
Microsatellite analysis
We analyzed four microsatellite markers (D8S503,
D8S520, D8S550 and D8S552) distributed along the
8p22-23.1 region, using publicly available primers and
standard PCR conditions. To detect and/or discard a puta-
tive duplication at those loci, we searched for extra allelesB
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Table 1: Summary of major clinical findings in Kabuki patients.
Sample KS1 KS2 KS3 KS4 KS5 KS6 KS7 KS8 KS9 KS10 KS11 KS12 KS13* KS14 * KS15 KS16 2q37.3 deletion
Age 20 months 5 years 10 years 10 years 4 years 7 years 2 years 2 years 8 years 8 months 12 years 10 years 20 years 17 years 8 years 8 months
Gender Female Female Male Female Male Female Male Male Male Male Male Male Female Male Male Female
Prenatal growth restriction +- + - - + - - + - - - - - - + -
Postnatal growth restriction + - - - -+++- - - + - + - + +
Microcephaly -- - + - - + - + + - + - - - + +
Craniofacial abnormality
Prominent forehead - +- - ----- - - - - +- - +
Long palpebral fissures - - - - +++++ + - + + + + + -
Lower palpebral eversion -- + - - - + - + - + + + + + + -
Arched eyebrows - ++ ++-+-- - - - + + - + +
Deep set eyes - - - - ----- - - - - +- - +
Blue sclerae + ++ - +-+-- + - - - - - + -
Short, upturned nose - - - - ----- - - - - - - - +
Depressed nasal tip + + + + +++-+ + - + - + - + -
Preauricular pit - - - - ----- - - + - - - - -
Prominent or dysmorphic ears + + + - +++++ - - + + + - + +
Cleft palate BU - - - BU - - - BU - - - - - + + -
Tented upper lip - ++ ++-+-- + + + + - + - -
High-arched palate + - - + -++++ - - + + + + +
Strabismus - +- - --- m o - - - + + - - +
Abnormal Dentition - +- - ----- - + - + +- -
Skeletal abnormality
Brachydactyly one finger or general + + + + +++- - - - + + - - + +
Short 5th finger with clinodactyly - -+ +----- - + + - - + -
Abnormal vertebrae/ribs - R H - - -----T R - - +D R - +
Scoliosis - - - - ----- - + ,  d o r s a l - - - - +
Joint laxity +- - + - - + - - - - + - - - +
Prominent finger tip pads + + + + +++++ + - + + + + -
Neurologyc abnormality
Hypotonia in infancy + + - + +++++ + - + + + + - +
Mental retardation mild mild - severe mild mild mild mild mild severe - mild mild mild mild mild +
Seizure + ++ - +-+-- - - - - - - - +
Visceral abnormality
Cardiovascular anomaly VSD - - - - ASD - - PDA - VSD, RAA, ASA - VSD - VSD +
Renal and urinary tract anomalies -- -- N B - - - P D - - - P D +
CNS malformation B A ,  H C C ,  C V - - - --- - - - +
Anogenital anomaly APA - - MG - - - NP - - - - - HC, APA +
Hearing
Recurrent otitis media +- +-- + -- - - + - -- +
Hearing loss +- - + S N + - - - - - - - +
Other TDAH, AS, SD AS, M MA, HH many
Analyzed by CGH array - + - - -++++ + - + - + + +
APA = anteriorly place anus; AS = Astigmatism; ASA = aberrant subclavian artery; ASD = Auricular septal defect; BA = brain atrophy; BU = bifid uvula; CV = Cerebellar vermis; DR = Deformed ribs; HCC 
= hypoplastic corpus callosum; HC = hypertrophic clitoris; HH = hiatal hernia; M = Myopia; MA = metatarsus adductus; MG = Macrogenitalia; NB = neurogenic bladder; NP = narrow penis; PD = pelvis 
dilatation; PDA = Patent Ductus Arteriosus; RAA = right aortic arch; SD = School delay; SN = sensori neural; TR = thin ribs; VSD = Ventricular septal defect; RH = rib hypoplasia; * Patients previously 
published [13]BMC Medical Genetics 2008, 9:27 http://www.biomedcentral.com/1471-2350/9/27
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and/or compared microsatellite allele peak ratios of
patients with those of their parents and controls.
Array-CGH
We have designed a microarray of 5442 large insert DNA
fragments (BACs) with a global coverage of 23% of the
euchromatic genome and much higher density in hot-
spot candidate regions, such as those located between seg-
mental duplications and all subtelomeres, named HSBA
(Hot-Spot-BAC-Array). BACs were selected from the
Sanger 1 Mb array kindly donated by JC Cigudosa, and
complemented with clones from the 32 K library [14]. The
distribution of BACs in the array is not homogeneous, but
the average spacing between consecutive clones is 0.5 Mb
and the maximum 1.2 Mb [see additional Table 1]. BAC
amplification was done by DOP-PCR as previously
described [15] and then spotted in 50% DMSO in tripli-
cate on Corning UltraGaps slides (VersArray ChipWritter
Pro™ System, Bio-Rad). Samples of 400 ng of genomic
DNA from each of the 10 patients with good quality DNA
were labeled by random priming with Cy3-dCTP and
Cy5-dCTP and hybridized in dye-swap experiments
against a reference pool of the same gender (either 50
females or 50 males). Hybridizations were done as
described by Wang et al. [16] using dextrane sulfate and
formamide as hybridization solution.
We also used a commercially available 60-mer oligonucle-
otide microarray for CGH, with probes located in coding
and noncoding sequences at an average spatial localiza-
tion of ~1/35 kb (Agilent G4410B). We hybridized the
samples following the manufacturer's protocol (v4), in
dye-swap experiments against the same reference pool.
For both arrays, images were obtained with an Agilent
Microarray Scanner (G2565BA) (Agilent Inc., Palo Alto,
CA) and raw data were extracted with the Genepix Pro 6.0
software (Axon, Inc.) using the irregular spot finding fea-
tures with default flagging settings. We normalized the
log2 ratios between the test sample and the reference pool
(M values) by using the print tip loess method. Simple
thresholds were used in order to detect DNA imbalances.
HSBA clones with all M replicate values outside the arbi-
trary range of |0.2| in both hybridization experiments
were considered as amplified (>0.2) or deleted (<-0.2).
Since oligonucleotide based arrays are noisier than BAC
arrays due to the smaller size of the probes and the paucity
of internal replicates [17], more stringent analyses were
done with G4410B data to minimize false positive results.
A potential rearrangement was considered only when 3
out of 3–5 consecutive probes gave M values outside |0.3|,
then obtaining an average resolution of ~1/100 kb [18].
The arbitrary thresholds were chosen in both cases based
on our previous lab experience (Vilardell et al. submitted
article "Statistical assessment of sources of systematic var-
iation in aCGH experiments").
Validation experiments
Confirmation of the CGH array results was done with dif-
ferent methodologies such as FISH on interphase and
metaphase cultured lymphocytes, and/or microsatellite
markers segregation and multiple ligation-probe amplifi-
cation (MLPA) [19] on genomic DNA.
FISH
BAC clone DNA was extracted by conventional alkaline
lysis from glycerol stocks or by DOP-PCR amplification.
The obtained DNA was fluorescently labeled using Spec-
trum-Red-dUTP (Vysis/Abbott) by nick translation and
hybridized by conventional methods on metaphase chro-
mosomes prepared from cultured lymphocytes from
patient samples.
MLPA
A total of 100 ng of genomic DNA from each sample was
subject to MLPA using specific synthetic probes [see Table
2 in additional file 1] designed to target the specific CNV
detected by aCGH. The MLPA reactions were analyzed on
an ABI PRISM 3100 Genetic analyzer according to manu-
facturers' instructions. Each MLPA signal was normalized
and compared to the corresponding peak height obtained
in at least 5 control DNA samples.
DNA paternity testing
Paternity was tested in patients with de novo rearrange-
ments KS2 and KS14. From each sample of the trios
(father, mother, child) we analyzed four microsatellite
markers of chromosome 7 (D7S642, D7S636, D7S2426,
D7S688) and two microsatellite markers of chromosome
15 (D15S1014, D15S207) using publicly available prim-
ers and standard PCR conditions.
Statistical methods
Statistical analysis was performed using the R-platform.
Multi test effect was corrected by the Benjamini-Hochberg
(BH) method [20] when it was necessary. In all cases sta-
tistical significance was considered for corrected p values
< 0.05. To search for putative association of CNVs with KS,
we compared the absolute frequencies of CNVs (number
of deletions, amplifications and no changes for each
CNV) between KS samples and controls. Differences were
assessed with the chi-square test using resampling with a
10,000 sample size instead of the reference chi-square dis-
tribution in order to avoid problems with the reduced
sample size. Furthermore, Fisher exact test was applied
when we compared the number of times that changes and
no-changes between Kabuki and controls were detected.
We repeated all tests twice, first with entire sample ofBMC Medical Genetics 2008, 9:27 http://www.biomedcentral.com/1471-2350/9/27
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patients, and then excluding the two cases with known
causal rearrangements.
Results
Lack of duplication at 8p22-23.1
Four microsatellite markers covering the 8p22-23 region
previously reported as duplicated were genotyped in all
patients using parental samples for allelic identification
and comparative sizing. We also analyzed 20 control indi-
viduals to establish the normal relative peak ratios in dif-
ferent allelic combinations. All patients were informative
(heterozyogous) at two or more of the analyzed loci and
none of the markers showed evidence of duplication in
this region (data not shown).
Detection of genomic imbalances in KS samples by aCGH
Using the HSBA array in the 10 KS samples with available
good quality DNA, a total of 109 autosomic BAC clones
detected copy number alterations (41 gains, 47 losses and
21 BACs with both gains and losses). Sixty six of these
BACs had previously been reported by different authors as
located within polymorphic CNVs [21-29] and 19 were
also detected as common variants in our control popula-
tion (20 controls and 130 patients with unrelated disor-
ders) [see Table 3 in additional file 1]. The remaining 24
BACs corresponding to genomic imbalances in 7 regions
were present only in KS samples and were consequently
considered as candidate regions for pathogenic involve-
ment in our patients (Table 2). Using the oligonucleotide
G4410B array, we validated most results of the HSBA array
and obtained additional information for regions that were
not covered by the BAC array (Table 2).
Confirmation and characterization of the genomic 
imbalances
The patient specific rearrangements found were the fol-
lowing (Table 2):
KS2 (Figure 1): The HSBA showed a duplication of 22
clones of chromosome 2q36.3-2q37.3 and a deletion of 7
clones in 2q37.3-qter. Microsatellite analysis with mark-
ers D2S126, D2S396, D2S206, D2S338, D2S125 and
D2S140, as well as FISH studies with BACs RP11-367B19
at 2q37.2 (red), RP11-637O3 at 2q37.3 (green) and
RP11-265M24 at 2q36.3 (green) confirmed a de novo
aberration originated in the maternal chromosome con-
sisting in a ~11 Mb inverted duplication in 2q36.3 and a
contiguous ~4.5 Mb terminal deletion of 2q37-qter previ-
ously unrecognized in the G-banded karyotype (Figure 2).
Paternity was confirmed using 6 additional microsatellite
markers.
KS6: No specific alterations were found with HSBA but
the G4410B array revealed an amplification of 12 consec-
utive probes encompassing ~392 Kb in 14q23.1. An
MLPA assay with two specific probes (ARID4A  and
KIAA0586  genes) showed that this duplication was a
paternally inherited CNV (Figure 3).
KS7:  A duplication of one BAC clone (RP11-506H20)
located in 5q11.2 was identified by the HSBA and then
validated by nine probes of the same region in the
G4410B array, defining a duplication of ~285 Kb. An
MLPA assay with a probe located in the UNG2  gene
showed a duplication pattern in the patient and his
mother, indicating that this duplication was also an inher-
ited CNV (Figure 3).
KS9: The HSBA array showed a deletion of one clone in
chr17q12, ratified by a deletion of three consecutive
probes of the Agilent array encompassing ~173 Kb in the
same interval containing the SLFN11 and SLFN12 genes.
MLPA with two specific probes for SLFN11 and SLFN12
genes showed a deletion in the patient and his mother
also indicating an inherited CNV (Figure 3).
KS12: The HSBA array showed the deletion of one BAC at
chr11q14.3 that was not confirmed by the G4410B array.
Using the defined criteria, five additional chromosomal
regions were identified by the oligo G4410B array. How-
ever, specific MLPA probes were designed for the genes
present in those regions and none of the presumed altera-
tions were confirmed despite the coincidence of some
MLPA and G4410B probes.
KS14 (Figure 1): A previous karyotype of this child and his
mother had showed an apparently balanced translocation
46,XY,t(15;17)(q15;q21) and no other rearrangement
[13]. The HSBA revealed a deletion of 10 terminal BAC
clones on chromosome 2q37.2-2qter and an additional
deletion of 3 BACs at chr16p11.2 (Figure 4). The G4410B
Agilent array confirmed a deletion of 101 probes covering
~7.2 Mb of 2q37.2-ter, as well as the deletion of 33 probes
covering ~0.5 Mb at 16p11.2. Microsatellite analysis at
loci D2S206, D2S338, D2S125 and D2S140, confirmed a
de novo 2q37 deletion in the paternally inherited chromo-
some, while the microsatellite D16S0531i revealed a de
novo 16p11 deletion of maternal origin (Figure 2). MLPA
with probes for two different genes (SPN and ALDOA)
further confirmed that the 16p11.2 deletion was also a de
novo event (Figure 4). Paternity was confirmed using 6
additional microsatellite markers.
We did not find specific genomic imbalances in any of the
remaining four KS samples analyzed by both aCGH tech-
nologies (KS8, KS10, KS15 and KS16).
Association analysis with CNVs
We then designed an MLPA panel including probes for all
rearrangements only detected in our patients and used toB
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Table 2: Patient specific rearrangements detected by aCGH
Sample Chr Band Start End Alteration Confirmed Origin Genes (within the BAC clone) Genes (Agilent Probe)
KS2 2 2q36.3-2q37.3 226400869 (225995608) 237338113 Gain 1,2 de novo (Maternal) COL4A4, COL4A3, SP140, LOC93349, 
SP100, INPPSD, ATG1GL1, SAG, DGKD, 
USP40, UGT1A8, UGT1A10, UGT1A9, 
UGT1A7, UGT1A6, DKFZp762E1312, 
TRPM8, SH3BP4 CENTG2 IQCA, CHKOR1
2 2q37.3 237607249 242166437 (telomere) Loss 1,2 de novo (Maternal) COPS8, UBE2F, SCLY, LOC339768 
TRAF31P1, ASB1 NDUFA10, ORGB2, 
ORGB3, MYEOV2, OTOS SEPT2, FARP2, 
STK25
KS6 14 14q23.1 57693088 (57541570) 58084505 (58177255) GAIN 3,4 Paternally inherited ACTR10, PSMA3, ARID4A, 
UNQ9438, TIMM9, KIAA0586
54849232 Maternally
KS7 5 5q11.2 54497449 (54489157) (54849173) GAIN 3,4 inherited FLJ37927, UNG2, DHX29, SKIV2L2 UNG2; SKIV2L2; PPAP2A
KS9 17* 17q12 30619177 (30610975) 30792737 (30797213) LOSS 3,4 Maternally inherited FLJ34922 SLFN11, SLFN12
2 2q37.2-2q37.3 235511580 (235053304) 242166437 (telomere) Loss 1,2,3 de novo (Paternal) SH3BP4 CENTG2 IQCA, CHKOR1, COPS8, 
UBE2F, SCLY, LOC339768 TRAF31P1, ASB1 
NDUFA10, ORGB2, ORGB3, MYEOV2, 
OTOS SEPT2, FARP2, STK25
KS14 16* 16p11.2 29546566 (29532360) 30106101 (30271412) Loss 2,3,4 de novo (Maternal) BOLA2, SPN, C16orf54, KIF22, MAZ TAOK2, 
HIRIP3, FLJ90652, DOC2A, 
DKFZP434I2117, ALDOA, PPP4C
SPN, QPRT, C16orf54, KIF22, 
MAZ, TAOK2, HIRIP3, 
FLJ90652, DOC2A, 
DKFZP434I2117, ALDOA, 
PPP4C, TBX6, YPEL3, GDPD3, 
MAPK3, CORO1A
1 = FISH, 2 = Microsatellite markers, 3 = Agilent oligo array G4410B, 4 = MLPA
Note that in the "Start and End" positions we have included the neighboring positions that were not altered in parenthesesBMC Medical Genetics 2008, 9:27 http://www.biomedcentral.com/1471-2350/9/27
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Facial phenotype of 2 Kabuki-like (A:KS2; B:KS14) and 2 Kabuki patients (C:KS7; D:KS12) Figure 1
Facial phenotype of 2 Kabuki-like (A:KS2; B:KS14) and 2 Kabuki patients (C:KS7; D:KS12). Note that KS2 and 
KS14 also show some features characteristic of the 2q37 deletion.BMC Medical Genetics 2008, 9:27 http://www.biomedcentral.com/1471-2350/9/27
Page 8 of 14
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Detection and validation of the 2q genomic imbalances Figure 2
Detection and validation of the 2q genomic imbalances. A and B: Plot of M-Values of clones on chromosome 2 and 
ideogram showing alterations in KS2 (A) and KS14 (B) patients. C: Microsatellite analysis showing the parental origin of these 
de novo alterations (KS2: Maternal chromosome; KS14: Paternal chromosome). D: FISH analysis with BACs RP11-367B19 (red) 
(2q37.2), RP11-637O3 (green) (2q37.3) and RP11-265M24 (green) (2q36.3) probes confirming de novo aberration originated in 
the maternal chromosome.BMC Medical Genetics 2008, 9:27 http://www.biomedcentral.com/1471-2350/9/27
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Electropherograms of MLPA assay with specific synthetic probes Figure 3
Electropherograms of MLPA assay with specific synthetic probes. A: Duplication pattern of probes for the ARID4A 
and KIAA0586 genes in the KS6 patient and her father. B: Duplication pattern of the UNG2 probe in KS7 patient and in his 
mother. C: Deletion pattern of two specific probes for SLFN11 and SLFN12 genes in the KS9 patient and his mother.BMC Medical Genetics 2008, 9:27 http://www.biomedcentral.com/1471-2350/9/27
Page 10 of 14
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Detection and validation of 16p11.2 deletion in KS14 Figure 4
Detection and validation of 16p11.2 deletion in KS14. A and B: Plot of M-Values of clones on chromosome 16 and ide-
ogram showing the deleted interval in the patient. C: Deletion patterns of MLPA at specific 16p11.2 probes (SPN and ALDOA 
genes) showing the de novo event in the patient with respect to parental samples and a control. D: Microsatellite analysis show-
ing the maternal origin of the de novo deletionBMC Medical Genetics 2008, 9:27 http://www.biomedcentral.com/1471-2350/9/27
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screen all samples, including those that had not been
studied by aCGH (KS1, KS3, KS4, KS5, KS11 and KS13).
None of the rearrangements was detected in any other
sample.
In order to detect possible associations of CNVs with KS,
we performed adjusted chi-square tests comparing the fre-
quencies of the 85 CNV regions detected by our analyses
[see Tables 3 and 4 in additional file 1] in KS samples ver-
sus controls. We included as controls both, ours and those
previously published by other control groups, mainly
HapMap samples [30]. We compared the presence or
absence of any of the alterations, as well as the potential
differences based on the type of alteration (amp/del/
none). Excluding the chromosome 2 rearrangements, we
detected 13 CNVs on average in KS samples and 12.4 in
our control population (no significant difference). Using
the chi-square and Fisher's test we did not detect associa-
tions with any CNV or CNV combination (corrected and
raw p values > 0.05) in the KS sample group.
Discussion
KS is a developmental syndrome with multisystemic
involvement but variable expressivity, most cases being
sporadic with a few exceptions of possible vertical trans-
mission in an autosomal dominant pattern. This presen-
tation highly suggests that KS could be caused by a
recurrent genomic disorder affecting more than one gene
[4]. To test this hypothesis, we have studied 16 Spanish
patients with clinical features suggestive of a diagnosis of
KS or KS-like, using molecular tools aimed at detecting
cryptic genomic imbalances. We decided not to use strict
clinical inclusion criteria with the idea that the molecular
characterization of patients with overlapping phenotypes
may provide clues to the final identification of the molec-
ular basis of specific syndromes.
We first ruled out in all cases gene dosage alterations at
8p22-8p23.1, the region previously reported to be dupli-
cated in six American KS patients (four Caucasian, one
African-American, and one Haitian) [5]. Our results, as
recently reported by others [6,8-11,31,32], do not support
the claim that genomic rearrangements of 8p22-8p23.1
are a common cause of KS.
To screen for putative submicroscopic genomic copy
number alterations in our KS and KS-like population, we
used two high throughput technologies based on aCGH
with different genomic coverage, a BAC array with high
density in putative hotspots for genomic disorders and a
gene-based oligo array. We did not detect any copy
number changes in the 20p12.1 region recently associated
with KS, covered by two BACs in the HSBA and 15 probes
in the G4410B array, further indicating that rearrange-
ments at this locus are not a common cause of KS [12].
Surprisingly, we found rearrangements of terminal 2q in
two patients (KS2 and KS14) with clinical manifestations
overlapping with the KS phenotype. In patient KS2, we
detected an inverted duplication with terminal 2q dele-
tion (invdup-del2q, invdup 11 Mb-del 4.5 Mb). In patient
KS14, who had a karyotype with an apparently balanced
translocation (t(15,17)) inherited from his mother [13],
we found two de novo unbalanced rearrangements: a 7.2
Mb terminal deletion of 2q37 in the paternal chromo-
some and a ~0.5 Mb interstitial deletion of 16p11.2 in the
maternal chromosome. Patterns of complex rearrange-
ments affecting several chromosomes and mostly gener-
ated in the paternal meiosis have been previously
described by aCGH in some patients with apparently bal-
anced de novo translocations [33,34], suggesting a com-
mon mechanism for those rearrangements. However in
KS14, no alterations were detected with any of the arrays
in the proximity to the breakpoints of the cytogenetically
balanced translocation inherited from the mother.
Therefore, we have detected overlapping rearrangements
of the long arm of chromosome 2 in two KS-like patients.
Although the rearrangements appear complex involving
dosage imbalance for additional chromosomal regions in
both cases, the region of overlap consists of a terminal
2q37 deletion of ~4,5 Mb. The long arm of chromosome
2 has a specific structure related to the ancestral fusion site
of two primate subtelomeric regions at 2q13 and a subte-
lomeric duplicated region of DNA enriched with CpG
islands [35]. To date, more than 60 patients with 2q37
deletions and a few rare cases with inverted duplications
of 2q have been described. In fact, inverted duplications
are thought to be recurrent rearrangements always associ-
ated with distal deletions [36]. Almost all patients with
2q37 deletions have some degree of mental retardation,
some with autistic features, and facial dysmorphism. Bra-
chymetaphalangism has been reported in approximately
of 50% of patients while congenital heart defects, pre-
dominantly atrial or ventricular septal defects or more
complex defects, are found in 20% of patients with 2q37
monosomy [37]. Phenotype-genotype correlations have
defined candidate regions to harbor the genes responsible
for congenital heart defects, brachymetaphalangysm and
neurobehavioural problems [37]. However, considerably
clinical variability was apparent even for patients with
similar breakpoints pointing to the existence of modifiers,
epigenetic or environmental phenomena also involved in
phenotypic variability.
Even though their specific common facial dysmorphism
(a round face with flat nasal bridge, dysmorphic ears often
prominent, deep-set eyes, anteverted nares and thin upper
lip) do not include long palpebral fissures with lateral
eversion of the lower third, bulbous depressed nasal tip,
or prominent ears with ear pits, characteristic of KS, theBMC Medical Genetics 2008, 9:27 http://www.biomedcentral.com/1471-2350/9/27
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private features of these two patients (Figure 1) made the
diagnosis of KS a possibility for our clinicians, considering
brachymetaphalangy with prominent fingertip pads, a
depressed nasal tip and prominent ears, mild to moderate
mental retardation and heart defects were present in both.
The phenotype in both patients was likely caused by addi-
tive effects of gene dosage imbalance of the 2q37 deletion
that included the critical interval for most phenotypic fea-
tures, and the additional rearrangement (2q36 duplica-
tion in KS2 and 16p11.2 deletion in KS14). However,
given this phenotypic overlap, we believe that the diagno-
sis of a 2q37 deletion should be considered in patients
with KS-like phenotypes where the characteristic eyes are
less evident, a feature that is often obvious only after 3
years of age.
The 16p11.2 interstitial deletion additionally found in
KS14 corresponds to a region flanked by segmental dupli-
cations that has been reported recently as one of the most
common recurrent genomic imbalances associated with
autism and developmental delay [38-40]. Interestingly,
both de novo and inherited deletions and duplications of
the region have been reported in ~1% of the ASD cases,
indicating that the 16p11 region carries a substantial sus-
ceptibility risk for autism. The same region was found
included in a new microdeletion syndrome in 16p11.2-
p12.2 reported in patients with mental retardation, dys-
morphic face and eye anomalies, even though the 0.5 Mb
deletion of our patient is not part of the common interval
but is included in the largest deletion reported in just one
patient [41]. However, KS14 did not show autistic features
nor eye anomalies, even though also several 2q37.3 dele-
tion syndrome patients have been reported to have autis-
tic features.
This region harbors multiple genes that could be dosage
sensitive and involved in the regulation of developmental
processes, one example being TBX6. Mouse embryos with
reduced levels of Tbx6 show defective somite patterning
of the paraxial mesoderm [42]. Therefore, it is tempting to
speculate that some of the phenotypic features of KS14,
such as the abnormal ribs, could be related with additive
effects involving haploinsufficiency for TBX6. The finding
of different parental origins for the chromosome 2q27
and the chromosome 16p11.2 deletions suggests that the
rearrangements are not mechanistically related and their
association must have occurred by chance.
The array technologies allow a rapid and automated eval-
uation of CNVs with genome-wide resolution.
We have detected three additional genomic alterations in
KS patients not found in other samples and not reported
as polymorphic CNVs in the published studies [21-27].
However, all three were inherited from a phenotypically
normal progenitor in each case, suggesting that they are
most likely polymorphic and non pathogenic rare CNVs.
Given that most CNVs are quite rare in the population, an
alternative hypothesis to the classic genomic disorder that
could be the cause of disease, KS in this case, would be the
additive effects of two or more rare CNVs. In our patient
population, we detected the presence of a total of 85
CNVs, 66 of which were previously reported as polymor-
phic [30] and the other 19 were identified as new variants
in our control populations. No patient specific combina-
tion of CNVs was found in the patients and the frequen-
cies of the 85 detected CNVs between KS and controls
showed no significant (p > 0.05) associations, suggesting
those regions do not contribute to the KS phenotype.
Conclusion
A major conclusion of our study is that we were unable to
find any common rearrangement causally related to KS.
The combination of a high resolution BAC array specifi-
cally enriched for putative hotspot regions and a commer-
cial 44 k oligo array (average resolution of 100 kb) failed
to identify any common deletion or duplication in typical
KS and KS-like patients, as previous reports using 1 Mb
resolution BAC arrays. The inclusion of two patients in
which a terminal 2q37 deletion syndrome could have
been clinically suspected, suggests there is some pheno-
typic overlap among the two conditions, and this diagno-
sis should be kept in mind when evaluating patients with
KS-like phenotypes. This study also supports that the 3.5
Mb duplication at 8p23.1-p22 is not the principal cause
nor a common cause of KS [6,8-11,31,32].
Although limited by the resolution of our arrays, our
results indicate that a recurrent copy number genomic
rearrangement affecting contiguous genes is unlikely to be
the common cause of KS. Other type of structural changes,
such as cryptic inversions, can not be ruled out with the
applied technology and remain a possible explanation.
Alternatively, KS could be caused by de novo genetic or epi-
genetic dominant alterations affecting a gene with pleio-
tropic effects, given that both concordant and discordant
monozygotic twins have been reported [43,44]. Further
studies with higher resolution array platforms are indi-
cated for typical and atypical patients suspected of having
KS, since no strict diagnostic criteria have yet been estab-
lished and no common etiology has yet been found.
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